EP 1682110 A1 20060726 - PHARMACEUTICAL COMPOSITION CONSISTING OF A BETA-3 ADRENOCEPTOR AGONIST AND AN ALPHA AGONIST
Title (en)
PHARMACEUTICAL COMPOSITION CONSISTING OF A BETA-3 ADRENOCEPTOR AGONIST AND AN ALPHA AGONIST
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG AUS EINEM BETA-3-ADRENOZEPTOR-AGONISTEN UND EINEM ALPHA AGONISTEN
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGONISTE DE L'ADRENOCEPTEUR BETA-3 ET UN AGONISTE ALPHA
Publication
Application
Priority
- EP 2004012272 W 20041029
- DE 10352132 A 20031104
Abstract (en)
[origin: WO2005046664A1] The invention relates to a new combination for treating dysfunction of the bladder, containing alpha agonists and a beta-3 adrenoceptor agonist.
IPC 8 full level
A61K 31/165 (2006.01); A61K 31/18 (2006.01); A61K 31/195 (2006.01); A61K 31/216 (2006.01); A61K 31/4164 (2006.01); A61K 31/4168 (2006.01); A61K 31/417 (2006.01); A61K 31/4178 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP US)
A61K 31/165 (2013.01 - EP US); A61K 31/18 (2013.01 - EP US); A61K 31/195 (2013.01 - EP US); A61K 31/216 (2013.01 - EP US); A61K 31/4164 (2013.01 - EP US); A61K 31/4168 (2013.01 - EP US); A61K 31/417 (2013.01 - EP US); A61K 31/4178 (2013.01 - EP US); A61P 13/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2005046664A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005046664 A1 20050526; CA 2544503 A1 20050526; DE 10352132 A1 20050609; EP 1682110 A1 20060726; JP 2007509897 A 20070419; US 2005154041 A1 20050714
DOCDB simple family (application)
EP 2004012272 W 20041029; CA 2544503 A 20041029; DE 10352132 A 20031104; EP 04791032 A 20041029; JP 2006537211 A 20041029; US 98106204 A 20041104